Clinical Trial Update: Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial exploring neoadjuvant chemoradiotherapy combined with perioperative toripalimab for locally advanced esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: RenJi Hospital | Conditions: Advanced Esophageal Squamous Cell Cancer | Phase 2 | Status: UNKNOWN